Ali Akhtar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ali Akhtar has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Perwez Alam
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
11 shared publications - Ali S. Alqahtani
Department of Pharmacognosy, College of Pharmacy, King Saudi University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Saudi Arabia
3 shared publications - Mohd Imran
R&D scientist, Aimil Pharmaceuticals, New Delhi, India
3 shared publications - Omer M. Almarfadi
Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
3 shared publications - Gadah Abdulaziz Al-Hamoud
Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
2 shared publications - Mohammed F. Hawwal
Department of Pharmacognosy College of Pharmacy King Saud University Riyadh Saudi Arabia
2 shared publications
Latest Publications
- 3 December 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 121, 108821
Mechanistic insights into marine-derived PDE6D inhibitors disrupting prenyl-binding to modulate leukemia-associated RAS trafficking
- 3 December 2025
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 121, 108821
Mechanistic insights into marine-derived PDE6D inhibitors disrupting prenyl-binding to modulate leukemia-associated RAS trafficking
- Open Access
- 2 October 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1405
A Review on Low-Dimensional Nanoarchitectonics for Neurochemical Sensing and Modulation in Responsive Neurological Outcomes
Low-Dimensional Nanohybrids (LDNHs) have emerged as potent multifunctional platforms for neurosensing and neuromodulation, providing elevated spatial-temporal precision, versatility, and biocompatibility. This review examines the intersection of LDNHs with artificial intelligence, brain–computer interfaces (BCIs), and closed-loop neurotechnologies, highlighting their transformative potential in personalized neuro-nano-medicine. Utilizing stimuli-responsive characteristics, optical, thermal, magnetic, and electrochemical LDNHs provide real-time feedback-controlled manipulation of brain circuits. Their pliable and adaptable structures surpass the constraints of inflexible bioelectronics, improving the neuronal interface and reducing tissue damage. We also examined their use in less invasive neurological diagnostics, targeted therapy, and adaptive intervention systems. This review delineates recent breakthroughs, integration methodologies, and fundamental mechanisms, while addressing significant challenges such as long-term biocompatibility, deep-tissue accessibility, and scalable manufacturing. A strategic plan is provided to direct future research toward clinical use. Ultimately, LDNHs signify a transformative advancement in intelligent, tailored, and closed-loop neurotechnologies, integrating materials science, neurology, and artificial intelligence to facilitate the next era of precision medicine.
- 2 October 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (10) , 1405
Open AccessA Review on Low-Dimensional Nanoarchitectonics for Neurochemical Sensing and Modulation in Responsive Neurological Outcomes
Low-Dimensional Nanohybrids (LDNHs) have emerged as potent multifunctional platforms for neurosensing and neuromodulation, providing elevated spatial-temporal precision, versatility, and biocompatibility. This review examines the intersection of LDNHs with artificial intelligence, brain–computer interfaces (BCIs), and closed-loop neurotechnologies, highlighting their transformative potential in personalized neuro-nano-medicine. Utilizing stimuli-responsive characteristics, optical, thermal, magnetic, and electrochemical LDNHs provide real-time feedback-controlled manipulation of brain circuits. Their pliable and adaptable structures surpass the constraints of inflexible bioelectronics, improving the neuronal interface and reducing tissue damage. We also examined their use in less invasive neurological diagnostics, targeted therapy, and adaptive intervention systems. This review delineates recent breakthroughs, integration methodologies, and fundamental mechanisms, while addressing significant challenges such as long-term biocompatibility, deep-tissue accessibility, and scalable manufacturing. A strategic plan is provided to direct future research toward clinical use. Ultimately, LDNHs signify a transformative advancement in intelligent, tailored, and closed-loop neurotechnologies, integrating materials science, neurology, and artificial intelligence to facilitate the next era of precision medicine.
- Open Access
- 1 November 2024
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (10)
Enhancing early detection of autistic spectrum disorder in children using machine learning approaches
- 1 November 2024
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 36 (10)
Open AccessEnhancing early detection of autistic spectrum disorder in children using machine learning approaches
- Open Access
- 23 October 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (11) , 11868-11889
Integrative Network Pharmacology, Molecular Docking, and Dynamics Simulations Reveal the Mechanisms of Cinnamomum tamala in Diabetic Nephropathy Treatment: An In Silico Study
Diabetic nephropathy (DN) is a serious diabetes-related complication leading to kidney damage. Cinnamomum tamala (CT), traditionally used in managing diabetes and kidney disorders, has shown potential in treating DN, although its active compounds and mechanisms are not fully understood. This study aims to identify CT’s bioactive compounds and explore their therapeutic mechanisms in DN. Active compounds in CT were identified using the Indian Medicinal Plants, Phytochemicals and Therapeutics database, and their potential targets were predicted with PharmMapper. DN-related targets were sourced from GeneCards, and therapeutic targets were identified by intersecting the compound–target and disease–target data. Bioinformatics analyses, including the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment studies, were performed on these targets. A protein–protein interaction network was constructed using STRING and Cytoscape. Molecular docking and dynamics simulations validated the most promising compound–target interactions. Six active compounds in CT were identified, along with 347 potential therapeutic targets, of which 70 were DN-relevant. Key targets like MMP9, EGFR, and AKT1 were highlighted, and the PPAR and PI3K-AKT signaling pathways were identified as the primary mechanisms through which CT may treat DN. CT shows promise in treating DN by modulating key pathways related to cellular development, inflammation, and metabolism.
- 23 October 2024
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (11) , 11868-11889
Open AccessIntegrative Network Pharmacology, Molecular Docking, and Dynamics Simulations Reveal the Mechanisms of Cinnamomum tamala in Diabetic Nephropathy Treatment: An In Silico Study
Diabetic nephropathy (DN) is a serious diabetes-related complication leading to kidney damage. Cinnamomum tamala (CT), traditionally used in managing diabetes and kidney disorders, has shown potential in treating DN, although its active compounds and mechanisms are not fully understood. This study aims to identify CT’s bioactive compounds and explore their therapeutic mechanisms in DN. Active compounds in CT were identified using the Indian Medicinal Plants, Phytochemicals and Therapeutics database, and their potential targets were predicted with PharmMapper. DN-related targets were sourced from GeneCards, and therapeutic targets were identified by intersecting the compound–target and disease–target data. Bioinformatics analyses, including the Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment studies, were performed on these targets. A protein–protein interaction network was constructed using STRING and Cytoscape. Molecular docking and dynamics simulations validated the most promising compound–target interactions. Six active compounds in CT were identified, along with 347 potential therapeutic targets, of which 70 were DN-relevant. Key targets like MMP9, EGFR, and AKT1 were highlighted, and the PPAR and PI3K-AKT signaling pathways were identified as the primary mechanisms through which CT may treat DN. CT shows promise in treating DN by modulating key pathways related to cellular development, inflammation, and metabolism.
- Open Access
Forecasting the Pharmacological Mechanisms of Plumbago zeylanica and Solanum xanthocarpum in Diabetic Retinopathy Treatment: A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Study
(1) Background: Diabetic retinopathy (DR) is a major complication of diabetes, marked by abnormal angiogenesis, microaneurysms, and retinal hemorrhages. Traditional Ayurvedic medicine advocates multi-target strategies for DR management. However, the mechanisms by which Solanum xanthocarpum (SX) and Plumbago zeylanica (PZ) exert therapeutic effects are not well understood; (2) Methods: To investigate these mechanisms, we employed network pharmacology and molecular docking techniques. Phytochemicals from SX and PZ were identified using the IMPPAT database and Swiss Target Prediction tool. DR-related protein targets were sourced from the GeneCards database, and common targets were identified through Venn diagram analysis. STRING and Cytoscape were used to construct and analyze protein–protein interaction networks. Pathway enrichment was performed with Gene Ontology and KEGG databases; (3) Results: We identified 28 active phytoconstituents, targeting proteins such as EGFR, SRC, STAT3, AKT1, and HSP90AA1. Molecular docking and dynamics simulations confirmed the strong binding affinities of these compounds to their targets; (4) Conclusions: The study highlights the multi-target activity of SX and PZ, particularly in pathways related to EGFR tyrosine kinase inhibitor resistance and PI3K–AKT signaling. These findings provide valuable insights into their therapeutic potential for DR, suggesting the effective modulation of key molecular pathways involved in the disease.
Open AccessForecasting the Pharmacological Mechanisms of Plumbago zeylanica and Solanum xanthocarpum in Diabetic Retinopathy Treatment: A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation Study
(1) Background: Diabetic retinopathy (DR) is a major complication of diabetes, marked by abnormal angiogenesis, microaneurysms, and retinal hemorrhages. Traditional Ayurvedic medicine advocates multi-target strategies for DR management. However, the mechanisms by which Solanum xanthocarpum (SX) and Plumbago zeylanica (PZ) exert therapeutic effects are not well understood; (2) Methods: To investigate these mechanisms, we employed network pharmacology and molecular docking techniques. Phytochemicals from SX and PZ were identified using the IMPPAT database and Swiss Target Prediction tool. DR-related protein targets were sourced from the GeneCards database, and common targets were identified through Venn diagram analysis. STRING and Cytoscape were used to construct and analyze protein–protein interaction networks. Pathway enrichment was performed with Gene Ontology and KEGG databases; (3) Results: We identified 28 active phytoconstituents, targeting proteins such as EGFR, SRC, STAT3, AKT1, and HSP90AA1. Molecular docking and dynamics simulations confirmed the strong binding affinities of these compounds to their targets; (4) Conclusions: The study highlights the multi-target activity of SX and PZ, particularly in pathways related to EGFR tyrosine kinase inhibitor resistance and PI3K–AKT signaling. These findings provide valuable insights into their therapeutic potential for DR, suggesting the effective modulation of key molecular pathways involved in the disease.
- Open Access
- 6 November 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (11) , 1561
Chitosan Nanoparticles for Enhanced Delivery of Sida cordifolia Extract: Formulation, Optimization and Bioactivity Assessment
In a continuous search for an essential antidiabetic agent, Sida cordifolia hydroalcoholic (SCHA) extract-loaded chitosan nanoparticles (SCHA-CS-NP) were optimized. The Box–Behnken design (BBD Design-Expert software, version 14) with three parameters was used to optimize the nanoparticles after creating them using the ion gelation method. The chitosan and Tween 20 contents and the stirring speed were chosen as the independent variables, and their separate and combined effects on particle size (Y1), polydispersity index (Y2) and entrapment efficiency (Y3) were observed. The optimized formulation showed a particle size of 51 nm, an entrapment efficiency of 84.54% and a polydispersity index of 0.391. Physicochemical characterization, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), a drug release study, an ex vivo permeation study, and an antioxidant study were performed. Confocal laser scanning microscopy (CLSM) images demonstrated that chitosan nanoparticles loaded with rhodamine B-laden SCHA extract had superior penetration compared to the control (rhodamine B solution). Furthermore, compared to conventional ascorbic acid (IC50 = 45 µg/mL), a superior antioxidant activity was discovered for SCHA-CS-NPs (IC50 = 86.45 ± 2.24 µg/mL), while SCHA-CS-NPs also exhibited strong antidiabetic potential (IC50 = 93.71 ± 1.79 µg/mL) compared to standard acarbose (IC50 = 97.25 ± 1.43 µg/mL). The overall results demonstrated that SCHA-CS-NPs are a promising and efficient formulation for oral delivery.
- 6 November 2023
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (11) , 1561
Open AccessChitosan Nanoparticles for Enhanced Delivery of Sida cordifolia Extract: Formulation, Optimization and Bioactivity Assessment
In a continuous search for an essential antidiabetic agent, Sida cordifolia hydroalcoholic (SCHA) extract-loaded chitosan nanoparticles (SCHA-CS-NP) were optimized. The Box–Behnken design (BBD Design-Expert software, version 14) with three parameters was used to optimize the nanoparticles after creating them using the ion gelation method. The chitosan and Tween 20 contents and the stirring speed were chosen as the independent variables, and their separate and combined effects on particle size (Y1), polydispersity index (Y2) and entrapment efficiency (Y3) were observed. The optimized formulation showed a particle size of 51 nm, an entrapment efficiency of 84.54% and a polydispersity index of 0.391. Physicochemical characterization, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), a drug release study, an ex vivo permeation study, and an antioxidant study were performed. Confocal laser scanning microscopy (CLSM) images demonstrated that chitosan nanoparticles loaded with rhodamine B-laden SCHA extract had superior penetration compared to the control (rhodamine B solution). Furthermore, compared to conventional ascorbic acid (IC50 = 45 µg/mL), a superior antioxidant activity was discovered for SCHA-CS-NPs (IC50 = 86.45 ± 2.24 µg/mL), while SCHA-CS-NPs also exhibited strong antidiabetic potential (IC50 = 93.71 ± 1.79 µg/mL) compared to standard acarbose (IC50 = 97.25 ± 1.43 µg/mL). The overall results demonstrated that SCHA-CS-NPs are a promising and efficient formulation for oral delivery.
- Open Access
Formulation of Transliposomal Nanocarrier Gel Containing Strychnine for the Effective Management of Skin Cancer
Strychnine (STCN) has demonstrated an exceptional anticancer effect against various cancers. However, the STCN clinical utility has been hampered by its low water solubility, restricted therapeutic window, short half-life, and significant toxicity. The objective of this investigation was to design and optimize a formulation of strychnine-loaded transliposomes (STCN–TLs) for dermal administration of STCN to treat skin cancer. The formulations of STCN–TL were examined in terms of vesicle size (VS), polydispersity index (PDI), entrapment efficiency (EE), and in vitro delivery. The improved STCN–TL formulation exhibited VS, PDI, EE, and in vitro delivery of 101.5 ± 2.14 nm, 0.218 ± 0.12, 81.74 ± 1.43%, and 85.39 ± 2.33%, respectively. In an ex vivo penetration, the created STCN–TL formulation demonstrated a 2.5-fold increase in permeability compared to the STCN solution. CLSM pictures of skin (rat) revealed that the rhodamine B-loaded transliposome preparation penetrated deeper than the rhodamine B hydroalcoholic mixture. Additionally, rat skin managed with STCN–TL nanogel exhibited a significant increase in Cskin max and AUC0-8 compared to rat skin treated with traditional STCN gel. The findings demonstrated that the transliposome preparation might be a suitable nanocarrier for the cutaneous distribution of STCN in the amelioration of skin cancer.
Open AccessFormulation of Transliposomal Nanocarrier Gel Containing Strychnine for the Effective Management of Skin Cancer
Strychnine (STCN) has demonstrated an exceptional anticancer effect against various cancers. However, the STCN clinical utility has been hampered by its low water solubility, restricted therapeutic window, short half-life, and significant toxicity. The objective of this investigation was to design and optimize a formulation of strychnine-loaded transliposomes (STCN–TLs) for dermal administration of STCN to treat skin cancer. The formulations of STCN–TL were examined in terms of vesicle size (VS), polydispersity index (PDI), entrapment efficiency (EE), and in vitro delivery. The improved STCN–TL formulation exhibited VS, PDI, EE, and in vitro delivery of 101.5 ± 2.14 nm, 0.218 ± 0.12, 81.74 ± 1.43%, and 85.39 ± 2.33%, respectively. In an ex vivo penetration, the created STCN–TL formulation demonstrated a 2.5-fold increase in permeability compared to the STCN solution. CLSM pictures of skin (rat) revealed that the rhodamine B-loaded transliposome preparation penetrated deeper than the rhodamine B hydroalcoholic mixture. Additionally, rat skin managed with STCN–TL nanogel exhibited a significant increase in Cskin max and AUC0-8 compared to rat skin treated with traditional STCN gel. The findings demonstrated that the transliposome preparation might be a suitable nanocarrier for the cutaneous distribution of STCN in the amelioration of skin cancer.
- Open Access
Formulation and Characterization of Hesperidin-Loaded Transethosomal Gel for Dermal Delivery to Enhance Antibacterial Activity: Comprehension of In Vitro, Ex Vivo, and Dermatokinetic Analysis
In this study, hesperidin was loaded into a transethosome and was developed employing the rotary evaporator method. The formulation was optimized using the Box–Behnken design (BBD). The optimized HSD-TE formulation has a spherical shape, vesicle size, polydispersity index, entrapment efficiency, and zeta potential within the range of 178.98 nm; the PDI was 0.259 with a zeta potential of −31.14 mV and % EE of 89.51%, respectively. The in vitro drug release shows that HSD-TE exhibited the release of 81.124 ± 3.45% in comparison to HSD suspension. The ex vivo skin permeation showed a 2-fold increase in HSD-TE gel permeation. The antioxidant activity of HSD-TE was found to be 79.20 ± 1.77% higher than that of the HSD solution. The formulation showed 2-fold deeper HSD-TE penetration across excised rat skin membranes in confocal laser microscopy scanning, indicating promising in vivo prospects. In a dermatokinetic study, HSD-TE gel was compared to HSD conventional gel where TE significantly boosted HSD transport in the epidermis and dermal layers. The formulation showed greater efficacy than free HSD in the inhibition of microbial growth, as evidenced by antibacterial activity on the Gram-negative and positive bacteria. These investigations found that the HSD-TE formulation could enhance the topical application in the management of cutaneous bacterial infections.
Open AccessFormulation and Characterization of Hesperidin-Loaded Transethosomal Gel for Dermal Delivery to Enhance Antibacterial Activity: Comprehension of In Vitro, Ex Vivo, and Dermatokinetic Analysis
In this study, hesperidin was loaded into a transethosome and was developed employing the rotary evaporator method. The formulation was optimized using the Box–Behnken design (BBD). The optimized HSD-TE formulation has a spherical shape, vesicle size, polydispersity index, entrapment efficiency, and zeta potential within the range of 178.98 nm; the PDI was 0.259 with a zeta potential of −31.14 mV and % EE of 89.51%, respectively. The in vitro drug release shows that HSD-TE exhibited the release of 81.124 ± 3.45% in comparison to HSD suspension. The ex vivo skin permeation showed a 2-fold increase in HSD-TE gel permeation. The antioxidant activity of HSD-TE was found to be 79.20 ± 1.77% higher than that of the HSD solution. The formulation showed 2-fold deeper HSD-TE penetration across excised rat skin membranes in confocal laser microscopy scanning, indicating promising in vivo prospects. In a dermatokinetic study, HSD-TE gel was compared to HSD conventional gel where TE significantly boosted HSD transport in the epidermis and dermal layers. The formulation showed greater efficacy than free HSD in the inhibition of microbial growth, as evidenced by antibacterial activity on the Gram-negative and positive bacteria. These investigations found that the HSD-TE formulation could enhance the topical application in the management of cutaneous bacterial infections.
- Open Access
HPLC-UV Analysis of Chrysophanol in Senna occidentalis Extract Obtained by Using the RSM-Optimized Ultrasonic Extraction Process
In this experiment, chrysophanol analysis in Senna occidentalis (aerial parts) extract obtained by optimizing ultrasound-assisted extraction (UAE) variables (temperature, time, and liquid-to-solid ratio) using response surface methodology (RSM) was performed by employing the HPLC-UV method. For UAE process optimization, a highly significant quadratic model (p < 0.001) was projected to attain maximum chrysophanol yield. The extraction temperature, time, and liquid-to-solid ratio for the best UAE method were determined to be 49.3 °C, 57.7 min, and 18.7 mL/g, respectively. The optimized extract was subjected to a chrysophanol analysis utilizing HPLC-UV (fitted with a Pinnacle C18 column), and a gradient mobile phase composed of 0.5% formic acid (solvent A), acetonitrile (solvent B), methanol (solvent C), at a flow rate of 1.0 mL/min, and an optimum wavelength of 279 nm, respectively. It furnished a compact and intense peak of chrysophanol at Rt = 23.809 min. The experimental value (20.47 mg/g) of chrysophanol obtained was close to the predicted value (19.32 mg/g), indicating that they agreed under the optimized extraction condition. UAE also displayed remarkable improvement in chrysophanol extraction compared with the conventional solvent extraction (CSE) method. Hence, our improved ultrasonic extraction process showed a potential use for effective chrysophanol extraction from commercial herbal supplements comprising the Senna species.
Open AccessHPLC-UV Analysis of Chrysophanol in Senna occidentalis Extract Obtained by Using the RSM-Optimized Ultrasonic Extraction Process
In this experiment, chrysophanol analysis in Senna occidentalis (aerial parts) extract obtained by optimizing ultrasound-assisted extraction (UAE) variables (temperature, time, and liquid-to-solid ratio) using response surface methodology (RSM) was performed by employing the HPLC-UV method. For UAE process optimization, a highly significant quadratic model (p < 0.001) was projected to attain maximum chrysophanol yield. The extraction temperature, time, and liquid-to-solid ratio for the best UAE method were determined to be 49.3 °C, 57.7 min, and 18.7 mL/g, respectively. The optimized extract was subjected to a chrysophanol analysis utilizing HPLC-UV (fitted with a Pinnacle C18 column), and a gradient mobile phase composed of 0.5% formic acid (solvent A), acetonitrile (solvent B), methanol (solvent C), at a flow rate of 1.0 mL/min, and an optimum wavelength of 279 nm, respectively. It furnished a compact and intense peak of chrysophanol at Rt = 23.809 min. The experimental value (20.47 mg/g) of chrysophanol obtained was close to the predicted value (19.32 mg/g), indicating that they agreed under the optimized extraction condition. UAE also displayed remarkable improvement in chrysophanol extraction compared with the conventional solvent extraction (CSE) method. Hence, our improved ultrasonic extraction process showed a potential use for effective chrysophanol extraction from commercial herbal supplements comprising the Senna species.
- Open Access
- 17 March 2023
- Published by MDPI AG in Separations
- Vol. 10 (3) , 208
Concurrent Optimization of Ultrasonic-Assisted Extraction of Total Phenolic Compounds and In Vitro Anticancer and Antioxidant Potential of Pulicaria schimperi (Aerial Parts) Using Response Surface Methodology
This study aimed to maximize the dependent variables [total phenolic content (TPC), antioxidant (DPPH and ABTS), and anticancer activities (against HepG2 and MCF-7 cells)] from P. schimperi aerial parts by optimizing three independent variables (extraction temperature, extraction time, and liquid-to-solid ratio) of ultrasound-assisted extraction (UAE) using the Box–Behnken design (BBD) of response surface methodology (RSM). For each of the dependent variables, the projected quadratic models were found to be very significant (p < 0.001). The extraction temperature and extraction time had a significant impact on the TPC extraction, antioxidant, and anticancer properties (p < 0.05). The best conditions were identified as an extraction temperature of 54.4 °C, extraction time of 48 min, and liquid-to-solid ratios of 20.72 mL/g for the simultaneous extraction of the TPC, antioxidant, and anticancer properties of P. schimperi. The experimental results and the expected values agreed under these circumstances. Regarding the high extraction effectiveness and antioxidant and anticancer effects at comparably low extraction temperature and duration, UAE demonstrated considerable benefits over conventional solvent extraction (CSE). This improved UAE approach has shown a potential use for effective polyphenolic antioxidant extraction from P. schimperi aerial parts in the nutraceutical sectors.
- 17 March 2023
- Published by MDPI AG in Separations
- Vol. 10 (3) , 208
Open AccessConcurrent Optimization of Ultrasonic-Assisted Extraction of Total Phenolic Compounds and In Vitro Anticancer and Antioxidant Potential of Pulicaria schimperi (Aerial Parts) Using Response Surface Methodology
This study aimed to maximize the dependent variables [total phenolic content (TPC), antioxidant (DPPH and ABTS), and anticancer activities (against HepG2 and MCF-7 cells)] from P. schimperi aerial parts by optimizing three independent variables (extraction temperature, extraction time, and liquid-to-solid ratio) of ultrasound-assisted extraction (UAE) using the Box–Behnken design (BBD) of response surface methodology (RSM). For each of the dependent variables, the projected quadratic models were found to be very significant (p < 0.001). The extraction temperature and extraction time had a significant impact on the TPC extraction, antioxidant, and anticancer properties (p < 0.05). The best conditions were identified as an extraction temperature of 54.4 °C, extraction time of 48 min, and liquid-to-solid ratios of 20.72 mL/g for the simultaneous extraction of the TPC, antioxidant, and anticancer properties of P. schimperi. The experimental results and the expected values agreed under these circumstances. Regarding the high extraction effectiveness and antioxidant and anticancer effects at comparably low extraction temperature and duration, UAE demonstrated considerable benefits over conventional solvent extraction (CSE). This improved UAE approach has shown a potential use for effective polyphenolic antioxidant extraction from P. schimperi aerial parts in the nutraceutical sectors.